@DocConTOC Justo como lo comentas, por ese rango dx tan limitado no es un criterio de calidad, toma más tiempo, mas efectos adversos propios el procedimiento y/o sedación; me imagino que este es la RCT con metanalisis que comentas, un must sin duda.
@drkeithsiau The decision to do an endoscopy it’s made by pretest probability, having a clean DRE does not exclude an upper GI hemorrhage. Old habits die hard
The Fifth Mexican consensus on the diagnosis and treatment of Helicobacter pyloriinfection
🔺PCAB and more PCAB
🔺Doxycycline > Tetracycline ?
https://t.co/zAdSTb1pF7
Empirical Antifungal Therapy Improves Survival in patients with Acute-on-Chronic Liver Failure with Suspected Invasive Fungal Infections: A Pragmatic Randomised Trial
🔺Practice changer? As ID doctors, should we hide or show this data?
https://t.co/vbMOx15gIk
📑First Latin American consensus on the treatment and prophylaxis of hepatic encephalopathy.
☑️LOLA for primary prophylaxis in variceal bleeding.
☑️WH III and IV: lactulose +rifaximin + LOLA
❌Probiotics and BCAA.
https://t.co/G1K2zzx34i
📑Point-of-care ultrasound (POCUS)–guided volume management and the effect of cirrhotic cardiomyopathy on acute kidney injury outcomes in cirrhosis
DOI: 10.1097/HEP.0000000000001524
💬 Editorial: The BICARICU-2 trial finds IV sodium bicarbonate may delay or reduce kidney replacement therapy in #criticallyill patients with severe #acidemia and #AKI, but its effect on mortality remains uncertain.
#LIVES2025@ESICM
https://t.co/Lvf3wiQMP5
📑Rifaximin Versus Low FODMAP Diet in Irritable Bowel Syndrome. Single blind, single center, RCT
Rfx and LFD effective in placebo control trials but there´s not a direct comparison
Outcome: Composite symptom improvement
☑️No difference between Rfx and lFD
https://t.co/e6EAFr9wRC
📄Proton Pump Inhibitor Use in Patients with Cirrhosis and Its Association With Spontaneous Bacterial Peritonitis.
❌ There's no association between the use of PPI against no PPI as a risk factor of SBP.
https://t.co/Zr3tcu9wAI
📑Evidence-based criteria for identifying at-risk individuals requiring liver disease screening.
🟢A way to predict LSM >12kPa based in two steps with risk factors (CLivD score, AST:ALT ratio, metabolic syndrome) and then a FIB-4 >1.3.
DOI: 10.1097/HC9.0000000000000679
📑The 2024 diagnostic criteria for primary sclerosing cholangitis.
-The past criteria were made only for Large Duct PSC.
-2024 diagnostic criteria are also designed for diagnosing small duct PSC and PSC recurrence following LTx.
https://t.co/PWvcfhZqBN
📑British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in Adults.
First guidelines specifically for the dietary management of chronic constipation. Evidence-based recommendations.
https://t.co/zK9V8xvZNj